Table 3.
Concomitant antibiotics administered
Days of concomitant rifampin exposure (N=23,701) | |
---|---|
Vancomycin | 18,270 (77%) |
Penicillins | 4175 (18%) |
Cephalosporins | 2425 (10%) |
Linezolid | 734 (3%) |
Clindamycin | 702 (3%) |
Carbapenems | 628 (3%) |
Trimethoprim/sulfamethoxazole | 134 (1%) |
Daptomycin | 29 (0.1%) |